QUICKLINKS AND VIEW OPITONS
Taranabant side effects : Dropouts to due to side effects : 13% with 2 mg vs 10% with placebo
Tuesday, April 01, 2008 6:49 am Email this article
Those given taranabant were more likely to dropout of the study than those given a placebo:
- 13 percent of those given 2 mg
- 10 percent of those given a placebo.
Study results here
The study results are posted here.
Merck & Co., Inc. Phase iii data showed taranabant, merck’s investigational medicine to treat obesity, led to statistically significant weight loss. Press release issued by Merck & Co, Inc. 2008 Mar 31.
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.